Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,120,169
-$97,545 QoQ
Shares Held
82,172
-1.9% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#143
of 469 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EFG International AG holds $93,313,047 across 41 Biotechnology names. BBIO ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
122,804 | $9,737,127 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
27,104 | $8,159,115 | |
| 3 | ARGX |
Argenx SE
|
8,573 | $7,953,772 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
This page
|
82,172 | $6,120,169 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
110,634 | $6,084,870 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
15,304 | $5,688,036 | |
| 7 | VCEL |
Vericel Corp
|
127,642 | $5,678,792 | |
| 8 | INSM |
INSMED Inc
|
50,941 | $5,431,328 |
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,120,169 | 82,172 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,217,714 | 83,729 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,750,624 | 88,255 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||